Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-26

Clinical Trial Update: Local Pharmacokinetics and Tolerability of Bimatoprost Applied to the Scalp of Male Patients With Androgenetic Alopecia [Phase 1]

View source ↗

Summary

This Phase 1 trial assesses the local pharmacokinetics and tolerability of applying bimatoprost to the scalp in men with androgenetic alopecia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bimatoprost (bimatoprost)

Snippet

Sponsor: Allergan | Conditions: Androgenetic Alopecia | Phase 1 | Status: COMPLETED